SEATTLE, July 22, 2021, (MEDGADGET) — Overview
Interventional pain management is a pain-relieving treatment that includes operations such as pain-relieving injections and spinal cord stimulation. At pain management clinics or centers, qualified anesthesiologists administer interventional pain control treatments. Joint pain, diabetic neuropathy, neck and back pain, ankle and foot pain, and cancer pain are among the conditions for which these treatments are commonly employed.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2273
The growing incidence of chronic pain is projected to boost demand for interventional pain management techniques in the near future, boosting the global interventional pain management market. As per a research released by the NCBI (National Center for Biotechnology Information) in 2015, roughly 19.6% of people aged 20 to 60 had low b levels.
Lower back discomfort affects roughly 20.3 percent of the population in the U.S., as per a report released by the CDC (Centers for Disease Control and Prevention) in 2012. According to the AAPM (American Academy of Pain Medicine) 2012 study, 11.9 million from cancer each year, more than 100 million people in the U.S. suffer from chronic pain, 16.3 million from coronary heart disease, and 25.8 million from diabetes, with the number expected to rise in the near future. Furthermore, the NIH (National Institutes of Health) projected in 2015 that one out of every ten adults in the U.S. suffers from chronic pain. Chronic pain affects one-third to 50 % of the population in the U.K., as per a research published in the British Medical Journal in 2016.
During the forecast period, the global interventional pain management market is projected to benefit from the increased formation of new national interventional pain management platforms. NexPhase Capital, LP purchased Gulf Coast Pain Institute in February 2018, and the business developed Clearway Pain Solutions Institute, a new national interventional pain management platform that would deliver interventional pain management treatments to patients suffering from chronic illness.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2273
Chronic pain is quite common in the senior population. As a result, as the world’s population ages, demand for interventional pain treatment is projected to rise, propelling global interventional pain management market development during the forecast period. As per the United Nations Population Fund, people aged 60 and up made up 12.3 percent of the worldwide population in 2015, and this number is predicted to rise to 22 percent by 2050, equivalent to 2 billion people.
Due to increased promotional initiatives by interventional pain management providers to raise knowledge about interventional pain management procedures among the populace, the interventional pain management market in North America is forecast to rise dramatically. The Center for Interventional Pain and Spine created a new website in 2016 to raise public knowledge about interventional pain management procedures.
In Europe, the rising prevalence of chronic pain is estimated to stimulate market expansion in interventional pain management in the near future. As per data provided by the World Health Organization (WHO) in 2015, chronic pain affected over 20% of the adult population in Europe.
The Asia Pacific region’s growing elderly population is predicted to boost demand for interventional pain treatment, propelling the region’s interventional pain management market forward. As per the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) figures from 2016, the Asia Pacific area accounts for over 60% of the world’s elderly population. In 2016, over 547 million individuals in the Asia Pacific area were over the age of 60, and this figure is projected to quadruple by 2050, reaching over 1.3 billion.
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/2273
Major companies contributing in the global interventional pain management market are Merz GmbH, Medytox Inc., Allergan Plc., Ipsen group, St. Jude Medical, Inc., Boston Scientific Corporation, and Medtronic Plc.
Table of Content
Global Interventional Pain Management Market Research Report
Section 1: Global Interventional Pain Management Industry Overview
Section 2: Global Economic Impact on Interventional Pain Management Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Interventional Pain Management Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Interventional Pain Management Market Forecast
Have a Look at Related Research Insights:
Pharmacy Benefit Management Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Practice Management System (PMS) Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Non-invasive Pain Management Devices Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027